Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery
Abstract Background Hepatocellular carcinoma (HCC) is a malignant tumor that threatens global human health. High PKM2 expression is widely reported in multiple cancers, especially in HCC. This study aimed to explore the effects of PKM2 on global gene expression, metabolic damages, patient prognosis,...
Main Authors: | Wen-Wen Lv, Dahai Liu, Xing-Cun Liu, Tie-Nan Feng, Lei Li, Bi-Yun Qian, Wen-Xing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-5023-0 |
Similar Items
-
Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
by: Liu T, et al.
Published: (2020-02-01) -
PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
by: Sean P. Martin, et al.
Published: (2020-06-01) -
HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
by: Qiuran Xu, et al.
Published: (2017-12-01) -
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
by: Jiao Feng, et al.
Published: (2019-05-01) -
Analysis of factors affecting the prognosis of transcatheter arterial chemoembolization for hepatitis B-related hepatocellular carcinoma
by: Jiangping Cun, et al.
Published: (2021-05-01)